IDYA•benzinga•
IDEAYA Announced Interim Phase 2 Clinical Results for Darovasertib and Crizotinib Synthetic Lethal Combination in Metastatic Uveal Melanoma; Tumor Shrinkage Observed in 31 of 35 Any-Line MUM Patients
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 11, 2022 by benzinga